financial results
NanoString Technologies Touts Interest in CosMx Spatial Biology Platform at JPM
The Seattle-based company has already sold 20 platforms ahead of the Q4 launch, and researchers are receiving data from the CosMx Technology Access Program.
Bionano Genomics Expecting Sharp Increases in Q4, Full-Year 2021 Revenues
The San Diego-based company said the installed base of its Saphyr optical genome mapping system reached 164 at the end of the year, topping expectations.
PacBio Prelim Q4 Revenues up 33 Percent; Firm Partners With Google, Berry Genomics, Genomics England
PacBio reported preliminary Q4 revenues of $36 million and full-year revenues of about $130.5 million, both falling short of analyst estimates.
Akoya, Olink, NanoString, Adaptive Bio, Sema4, Oxford Nanopore Report Preliminary Financial Results
The life science tools companies provided anticipated revenue results for the fourth quarter and full-year 2021.
CareDx, Castle Bio, Lucira Health, Others Announce Preliminary Q4, FY21 Earnings Results
CareDx's Q4 revenues rose between 34 percent and 35 percent, while OpGen Q4 revenues were flat compared to the previous year.
Dec 15, 2021
Enzo Biochem Q1 2022 Revenues Down 8 Percent
Nov 22, 2021
Agilent Q4 Revenues Rise 12 Percent
Nov 16, 2021
Burning Rock Q3 Revenues Inch up 2 Percent
Nov 15, 2021
Sema4 Q3 Revenues Rise 12 Percent
Nov 15, 2021
SomaLogic Q3 Revenues Grow 40 Percent
Nov 12, 2021
Meridian Bioscience Q4 Revenues Climb 19 Percent
Nov 12, 2021
OpGen Q3 Revenues Climb 9 Percent
Nov 11, 2021
Lucira Health Posts $15M in Q3 Revenues
Nov 11, 2021